SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antex Biologics (ANTX)
ANTX 1.190+1.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Amigo Mike who wrote (720)2/28/1998 8:52:00 AM
From: Ted Downs  Read Replies (1) of 1476
 
Michael,
I doubt Glaxo Will pull off a buyout of SKB.

I think you are 100% correct about that. Although I feel that SKB is now in play so they may make a deal more favorable to their board with someone else anyway. Hopefully Glaxo loses since they won't get in a bidding war in my opinion. This is typical of British and European companies to try to buy cheap like British Telecom tried with MCI and lost out.

Regardless, if SKB does get bought out there is always a risk funding could be impaired. If antx gets far enough along in trials they won't be as dependant for research money until they can make a production/distribution deal.

Ted
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext